Literature DB >> 27726044

Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism.

Radwan Kassir1,2, Jean Gugenheim3, Tarek Debs3, Imed Ben Amor3, Olivier TIffet4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27726044     DOI： 10.1007/s11695-016-2406-7

Source DB:  PubMed          Journal:  Obes Surg        ISSN： 0960-8923            Impact factor:   4.129


× No keyword cloud information.
  3 in total

1.  Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes.

Authors:  Charlotte de Jonge; Sander S Rensen; Hedwig M A D'Agnolo; Nicole D Bouvy; Wim A Buurman; Jan Willem M Greve
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

2.  Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism.

Authors:  Nuria Vilarrasa; Amador García Ruiz de Gordejuela; Anna Casajoana; Xevi Duran; Silvia Toro; Eduard Espinet; Manoel Galvao; Joan Vendrell; Rafael López-Urdiales; Manuel Pérez; Jordi Pujol
Journal:  Obes Surg       Date:  2017-03       Impact factor: 4.129

3.  Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.

Authors:  Rodrigo Muñoz; Angelica Dominguez; Fernando Muñoz; Cesar Muñoz; Milenko Slako; Dannae Turiel; Fernando Pimentel; Alan Sharp; Alex Escalona
Journal:  Surg Endosc       Date:  2013-11-07       Impact factor: 4.584
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.